United States · FDA National Drug Code directory
pimecrolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0591-2944_a3f0bc92-796c-4f74-8c7a-63001b4e9e43
- Product NDC
- 0591-2944
- Form
- CREAM
- Composition / generic term
- pimecrolimus
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181227
- Source listing expiry
- 20261231
Source-listed ingredients
- PIMECROLIMUS — 10 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 30 g in 1 TUBE (0591-2944-30) · 0591-2944-30
- 60 g in 1 TUBE (0591-2944-60) · 0591-2944-60
- 100 g in 1 TUBE (0591-2944-87) · 0591-2944-87
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →